Welcome to the FUNNY trial.
The FUNNY trial is an international, phase IIa, triple blind, placebo controlled randomised trial, targeting heart rate control using the funny current inhibitor ivabradine, to reduce morbidity in patients undergoing non-cardiac surgery.
Ivabradine Summary of Product Characteristics (SmPC) [PDF 209KB]
The trial started in Jan 2022 at the Royal London Hospital - with others to join. Patients will be enrolled over a three-year recruitment window across all hospitals.
As the trial progresses, the website will be regularly updated with the latest news and documents for you to freely access. For any trial related queries, please directly contact the trial management team.
The FUNNY trial team
The FUNNY trial is funded by...